| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Neurology (H.S., S.M.R., A.A., R.M., L.D.K., J.C.v.S.), Neuropsychology (I.d.K.), and Clinical Genetics (J.A.M.-K., G.J.B., D.D.), Erasmus Medical Center, Rotterdam; and Department of Human Genetics (B.A., I.F.B., P.R.), Center for Neurogenomics and Cognitive Research (B.A., I.F.B., P.R.), and Neuropathology (W.K., J.M.R.), VU University Medical Center and VU University, Amsterdam.
* To whom correspondence should be addressed. E-mail: j.c.vanswieten{at}erasmusmc.nl.
Background: Frontotemporal dementia (FTD) is the second most common type of presenile dementia and can be distinguished into various clinical variants. The identification of MAPT and GRN defects and the discovery of the TDP-43 protein in FTD have led to the classification of pathologic and genetic subtypes. In addition to these genetic subtypes, there exist familial forms of FTD with unknown genetic defects.
Methods: We investigated the frequency, demographic, and clinical data of patients with FTD with a positive family history in our prospective cohort of 364 patients. Genetic analysis of genes associated with FTD was performed on all patients with a positive family history. Immunohistochemical studies were carried out with a panel of antibodies (tau, ubiquitin, TDP-43) in brains collected at autopsy.
Results: In the total cohort of 364 patients, 27% had a positive family history suggestive for an autosomal mode of inheritance, including MAPT (11%) and GRN (6%) mutations. We identified a new Gln300X GRN mutation in a patient with a sporadic FTD. The mean age at onset in GRN patients (61.8 ± 9.9 years) was higher than MAPT patients (52.4 ± 5.9 years). In the remaining 10% of patients with suggestive autosomal dominant inheritance, the genetic defect has yet to be identified. Neuropathologically, this group can be distinguished into familial FTLD+MND and familial FTLD-U with hippocampal sclerosis.
Conclusion: Future genetic studies need to identify genetic defects in at least two distinct familial forms of frontotemporal dementia (FTD) with unknown genetic defects: frontotemporal lobe degeneration with ubiquitin-positive inclusions with hippocampal sclerosis and frontotemporal lobe degeneration with motor neuron disease.
Related Article
This article has been cited by other articles:
|
|
 |
|
  J. D. Rohrer, R. Guerreiro, J. Vandrovcova, J. Uphill, D. Reiman, J. Beck, A. M. Isaacs, A. Authier, R. Ferrari, N. C. Fox, et al. The heritability and genetics of frontotemporal lobar degeneration Neurology, November 3, 2009; 73(18): 1451 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Hodges, J. Mitchell, K. Dawson, M. G. Spillantini, J. H. Xuereb, P. McMonagle, P. J. Nestor, and K. Patterson Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases Brain, October 5, 2009; (2009) awp248v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Bird Progranulin plasma levels in the diagnosis of frontotemporal dementia Brain, March 1, 2009; 132(3): 568 - 569. [Full Text] [PDF]
|
|
|
|
 |
|
 Major Genetic Subtypes of Frontotemporal Dementia Journal Watch Neurology, February 3, 2009; 2009(203): 2 - 2. [Full Text]
|
|
|
|
|
|
M. Grossman Is the glass half empty or half full?: Genetically determined disease in frontotemporal dementia Neurology, October 14, 2008; 71(16): 1216 - 1217. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
